Look out, EpiPen. With Adamis deal, Novartis is gunning for your sales
admin 2nd July 2018 Uncategorised 0Novartis has decided to jump onto EpiPen’s playing field. The Swiss drugmaker’s Sandoz unit snapped up U.S. rights to Symjepi, the Adamis Pharmaceuticals prefilled epinephrine syringe, putting its commercial heft behind the push to gain ground against Mylan’s blockbuster.
More: Look out, EpiPen. With Adamis deal, Novartis is gunning for your sales
Source: fierce